Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer
Open Access
Abstract
(1) Background: Yes-associated protein 1 (YAP1) is an oncogene activated under the dysregulated Hippo pathway. YAP1 is also a mechanotransducer that is activated by matrix stiffness. So far, there are no in vivo studies on YAP1 expression related to stiffness. We aimed to investigate the association between YAP1 activation and tumor stiffness in human breast cancer samples, using immunohistochemistry and shear-wave elastography (SWE). (2) Methods: We included 488 patients with treatment-naïve breast cancer. Tumor stiffness was measured and the mean, maximal, and minimal elasticity values and elasticity ratios were recorded. Nuclear YAP1 expression was evaluated by immunohistochemistry and tumor-infiltrating lymphocytes (TILs); tumor-stroma ratio (TSR) and stroma type of tumors were also evaluated. (3) Results: Tumor stiffness was higher in tumors with YAP1 positivity, low TILs, and high TSR and was correlated with nuclear YAP1 expression; this correlation was observed in hormone receptor positive (HR+) tumors, as well as in tumors with non-collagen-type stroma. (4) Conclusions: We confirmed the correlation between nuclear YAP1 expression and tumor stiffness, and nuclear YAP1 expression was deemed a prognostic candidate in HR+ tumors combined with SWE-measured tumor stiffness.Keywords
Funding Information
- Yonsei University College of Medicine (6-2021-0159, 6-2022-0123, NRF-2021R1G1A109359612)
- National Research Foundation of Korea (6-2021-0159, 6-2022-0123, NRF-2021R1G1A109359612)
This publication has 46 references indexed in Scilit:
- Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblastsNature Cell Biology, 2013
- Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profileBreast Cancer Research and Treatment, 2013
- Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomasBreast Cancer Research and Treatment, 2011
- Hippo Pathway Effector Yap Is an Ovarian Cancer OncogeneCancer Research, 2010
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Yes-associated protein (YAP) functions as a tumor suppressor in breastCell Death & Differentiation, 2008
- The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAPCell, 2005
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986